ESP vs REGN · P/E 15, rev $9.6M vs P/E 14, rev $14.34B
Espey Mfg & Electronics Corp (ESP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Espey Mfg & Electronics Corp (ESP) is a electrical equipment & parts company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ESP revenue for 2025-06-30 was $9.6M. Net income was $2.9M. Revenue was down 6.9% from 2025-03-31 to 2025-06-30. ESP currently screens at market cap $173.6M and trailing P/E 15.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ESP currently screens at market cap $173.6M and trailing P/E 15.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ESP and REGN stock pages for the full models.
Not investment advice.